- Report
- June 2025
- 400 Pages
Global
From €4318EUR$4,949USD£3,750GBP
- Report
- June 2025
- 400 Pages
Global
From €4318EUR$4,949USD£3,750GBP
- Report
- June 2025
- 400 Pages
Global
From €4318EUR$4,949USD£3,750GBP
- Report
- June 2025
- 400 Pages
Global
From €4318EUR$4,949USD£3,750GBP
- Report
- June 2025
- 400 Pages
Global
From €4318EUR$4,949USD£3,750GBP
- Report
- June 2025
- 400 Pages
Global
From €4318EUR$4,949USD£3,750GBP
- Report
- May 2025
- 300 Pages
Global
From €4318EUR$4,949USD£3,750GBP
- Report
- January 2026
- 180 Pages
Global
From €3926EUR$4,500USD£3,410GBP
- Report
- April 2025
- 185 Pages
Global
From €3926EUR$4,500USD£3,410GBP
- Report
- August 2025
- 150 Pages
Global
From €3447EUR$3,950USD£2,993GBP
- Report
- May 2025
- 125 Pages
Global
From €4145EUR$4,750USD£3,599GBP
- Report
- November 2025
- 145 Pages
Global
From €3447EUR$3,950USD£2,993GBP
- Report
- January 2026
- 142 Pages
Global
From €5104EUR$5,850USD£4,433GBP
- Report
- January 2026
- 331 Pages
Global
From €5104EUR$5,850USD£4,433GBP
- Report
- January 2026
- 246 Pages
Global
From €5104EUR$5,850USD£4,433GBP
- Report
- January 2026
- 292 Pages
Global
From €2181EUR$2,500USD£1,894GBP
- Report
- January 2026
- 291 Pages
Global
From €2181EUR$2,500USD£1,894GBP
- Report
- January 2026
- 277 Pages
Global
From €2181EUR$2,500USD£1,894GBP
- Report
- January 2026
- 304 Pages
Global
From €2181EUR$2,500USD£1,894GBP
- Report
- January 2026
- 280 Pages
Global
From €2181EUR$2,500USD£1,894GBP

The Drugs by Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs for specific medical conditions. These drugs are designed to treat a wide range of diseases, from cancer to mental health disorders. Companies in this market typically specialize in one or more therapeutic areas, such as oncology, neurology, or cardiology. They develop drugs that target specific medical conditions and then market them to healthcare providers and patients. Companies in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Sanofi. Show Less Read more